Page 42 - Best Doctors in the World

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Areas of Interests

• Demyelinating Diseases and MS
• Peripheral Neuropathy and Motor Neuron Disease (ALS)
• Neuromuscular Junction Diseases (MG)

Education 

• M.Sc. Faculty of Medicine, Ondokuz Mayıs University  1990
• Specialization in Medicine  Neurology,  Ankara Training and Research Hospital 1997
• Minor Specialization  Clinical Neurophysiology, Medical Specialization Board 2011

Experience

• Doctor MoH Kastamonu and Samsun Health Center No. 7 1990-1992
• Dr. Res.Assist. Ankara Training and Research Hospital Neurology Clinic 1992-1997
• Assoc. Dr. Abant İzzet Baysal University Düzce Faculty of Medicine 1999-2006
• Assoc.Dr. Duzce University Faculty of Medicine 2007-2011
• Prof.Dr  Duzce University Faculty of Medicine  2011-

Dr. Kim Kyu Hee is a board-certified surgeon. She specializes in plastic and aesthetic surgery. She completed her medical education at Soonchunhyang University. Dr. Kim trained at the university’s affiliated hospital, where she worked as an intern and resident. She later served as a full-time doctor and assistant administrator.

Dr. Kim is a member of several professional organizations. These include the Korean Society for Plastic Surgery, the Research Society for Breast Surgery, the Korean Medical Practitioners Association, and the Korean Society for Aesthetic Plastic Surgery.

Oncologist, specialist in gastrointestinal cancer treatment

Dr. Hwang Yoon Ju is a Family Medicine Specialist. She graduated from Konkuk University School of Medicine. She is a member of several professional societies. These include the Korean Society of Skin Beauty, the Korean Society for Skin Research, the Korean Medical Laser Society, the Korean Society of Aesthetic Surgery, the Korean Obesity Research Association, and the Obesity Body Type Association.

Dr. Hwang has broad clinical experience. She has worked at 365mc Hospital, Clinic of God, Renewme Dermatology, Lean Clinic, and DA Plastic Surgery. Her professional memberships and varied clinical roles show her expertise in skin care, aesthetic medicine, and obesity treatment.

Dr. Yoo Jang Seok graduated from Hanyang University. He is a member of several respected medical societies, such as the Korean Society for the Study of Obesity, the Korean Society of Cosmetic Surgery and Laser Medicine, and the Korean Society of Aesthetic Plastic Surgery. He also belongs to the Korean Academy of Cosmetic Surgery and the Korean Society of Obesity and Body Contouring.

Dr. Yoo has broad clinical experience. He has worked at Ro&Skin Dermatology, Seoksu Union Clinic, Miso Dream Dermatology, NU Dermatology, and Erne Clinic. His memberships and work history show his dedication to cosmetic surgery, dermatology, and obesity treatment.

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Dr. Idris Sertbas is a skilled neurosurgeon with experience in both adult and pediatric brain and spine surgeries. He performs complex procedures such as brain and cerebellum tumor surgeries. He also treats children with conditions like hydrocephalus, tethered cord, and craniosynostosis. Dr. Sertbas is experienced in advanced spine surgeries, including stabilization for disc herniation, vertebroplasty, and kyphosis surgery.

He is trained in neuromodulation surgeries, such as deep brain stimulation for Parkinson’s disease, epilepsy stimulation, and spinal cord stimulation for chronic pain. He also performs procedures for trigeminal neuralgia, hemifacial spasm, and baclofen pump implantation for severe spasticity.

Dr. Sertbas graduated from Sivas Cumhuriyet University and completed his neurosurgery training at Ankara Training and Research Hospital. He has worked at Bartın State Hospital and Istanbul Yeni Yüzyıl University. He now practices at the Neurosurgery Clinic of Liv Vadistanbul Hospital.

Kotchakorn stitstein,M.D

Specialist in Otolaryngology and Facial Plastic and Reconstructive Surgery

Graduated (M.D. From)

Doctor of Medicine, Phramongkutklao College of Medicine

Certificates

Certificate of Otolaryngology, Phramongkutklao Hospital

Subspecialty in Facial Plastic and Reconstructive Surgery, Chulalongkorn University

Work History (Experiences)

Otolaryngologist at Phramongkutklao Hospital

Current Positions

Otolaryngologist & Facial plastic & Reconstructive surgery at Intrarat Hospital

EDUCATION:

• Turhan and Mediha Tansel Primary School (1979–1984)
• Kültür College (1984–1988)
• Semiha Şakir High School (1988–1991)
• Marmara University Faculty of Medicine (1991–1997)
• Marmara University Faculty of Medicine, Neurosurgery Department, Specialist Training (1997–2002)
• Title of Associate Professor in Neurosurgery (May 31, 2021)

ADDITIONAL TRAINING:

• "Visiting Physician," University of Southern California, Department of Neurosurgery (1998)
• "Microsurgery Training," GATA (Gülhane Military Medical Academy), Ankara Education and Research Hospital (2003)

PROFESSIONAL EXPERIENCE:

• Gülhane Military Medical Academy Haydarpaşa Training and Research Hospital (2002–2003)
• Dr. Lütfi Kırdar Kartal Training and Research Hospital (2003–2005)
• Private Avicenna Ataşehir Hospital (2005–2012)
• Private 29 Mayıs Hospital (2012–2013)
• Maltepe State Hospital (2013–2018)
• Kartal Dr. Lütfi Kırdar City Hospital (2018–2020)
• Private Academic Hospital (2020–2022)
• Hisar Intercontinental Hospital (2022–2024)
• Private Medipol Acıbadem Regional Hospital (2024–Present)

ADMINISTRATIVE AND ACADEMIC ROLES:

• Board Member, Neurosurgical Society (2006–2009)
• Head of the Emergency Department, Maltepe State Hospital (2014–2016)
• Deputy Chief Physician, Private Academic Hospital (2020–2021)
• Advisory Board Member, Beykent University Faculty of Medicine (2018–2024)
• Faculty Member, Galata University Faculty of Health Sciences (2022–2024)
• Director, Continuous Education Center, Galata University (2022–2024)

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

• Completion of the degree at the FACULTY OF MEDICINE OF THE AUTONOMOUS UNIVERSITY OF MADRID (UAM) during the academic years 1975-76 to 1980-81, obtaining the title of Bachelor of Medicine and Surgery at the said University in JUNE 1981.
• A full-time student at the Department of Physiology, Faculty of Medicine, U.A.M., in the summers of 1977, 79, 80 and 81, he participated in various research projects and acquired basic knowledge in the field of fundamental research.

SPECIALTIES:

- Medical specialist in INTENSIVE CARE MEDICINE.

- Receiving position number 96 in the MIR call November 1981.

- Resident physician assigned to the Intensive Care Service of the Ramón y Cajal Hospital in Madrid from 1982 to 1986 (5 years) to develop a program in this specialty.

- Member of the Spanish Society of Intensive Medicine and Coronary Units (SEMIUC).

- Member of the editorial board of the EMERGENCIAS magazine.

- General practitioner assigned to the Department of Plastic and Reconstructive Surgery at the Hospital "Doce de Octubre" in Madrid, from April 1989 to December 1993. (5 years).

- Multiple member (No. 361) of the SPANISH SOCIETY OF REPARATIVE AND AESTHETIC PLASTIC SURGERY (SECPRE).

- Receiving FIRST PRIZE in the competition of resident doctors at the VI meeting of SECPRE in Granada, November 1992.

- Director of the International Symposium on Breast Reconstruction. Hospital 12 Octubre INSALUD, Madrid, 13, 14 and 15 November 1996.

- Representative member of the SPANISH SOCIETY OF RECONSTRUCTIVE AND AESTHETIC PLASTIC SURGERY to the EUROPEAN UNION OF MEDICAL SPECIALISTS (UEMS), from December 1994 to December 2000.

- Member of EBOPRAS (European Board of Plastic Reconstructive and Aesthetic Surgery) from December 1994 to December 2000.

- Vice-Secretary of the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery (SECPRE). Between 1997 and 1998.

- SECRETARY GENERAL of the Spanish Society of Reconstructive and Aesthetic Plastic Surgery (SECPRE), from January 1999 to December 2000.

- Delegate of Spanish plastic surgeons to the International Plastic, Reconstructive and Aesthetic Surgery (IPRAS). During 2000.

- Secretary General of the SECPRE Training Foundation. During 2001 and 2002.

- Member of the National Commission of Plastic and Reconstructive Surgery, representing the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery, from June 2000 to May 2004.

- Director of the II SYMPOSIUM: Breast Implants in Plastic Surgery. January 25-26, 2002.

- Co-director of the annual training course on augmentation mammoplasty 2004, held at the Monteprincipe Hospital in Madrid.

- Co-director of the annual training course on augmentation mammoplasty 2005, held at the Teknon Clinic in Barcelona.

- Member of the Spanish Society of Anti-Aging and Longevity Medicine.

PLASTIC SURGERY

1. Assistant surgeon to Dr. ANTONIO DE LA FUENTE GONZALEZ in the practice of plastic and aesthetic surgery from October 1989 to November 1993.

2. Conducting the IX PRACTICAL COURSE OF EXPERIMENTAL MICROSURGERY, at the ASEPEYO MONOGRAPHIC HOSPITAL, November 1989.

3. Periodic assistance to the Experimental Surgery Service of the Ramon y Cajal Center in Madrid for EXPERIMENTAL MICROSURGERY on rats from January 1990 to January 1995.

4. Assistance to the plastic surgery service of the Villa Salaria clinic in Rome (Italy) under the direction of Dr. M. Gasparotti in teaching the surgical technique of SUPERFICIAL LIPOSUCTION. December 1992.

5. Attendance at the CANNIESBERN FLAP COURSE, Canniesburn Hospital, Glasgow, England, March 1993.

6. Attendance at the 10th INTERNATIONAL COURSE IN PLASTIC AND AESTHETIC SURGERY at the Planas Clinic, Barcelona, June 1993.

7. Participation in the 1st SYMPOSIUM ON ADVANCES IN BREAST RECONSTRUCTION. Nashville. USA. Tennessee. May. 1995.

8. Attendance at the INTERNATIONAL COURSE IN PLASTIC-AESTHETIC SURGERY at the Planas Clinic. Barcelona. June 1996.

TEACHING ACTIVITIES

- PROFESSOR of Nursing at the SALUS INFIRMORUM School of Nursing (Madrid School) of the Pontifical University of Salamanca from 1984 to 1992.

- PROFESSOR of the Emergency Surgery Course of the Special Emergency Service (INSALUD). Madrid, 3–7 June 1991.

- PROFESSOR of the specialized course "OUT-OF-HOSPITAL MEDICAL EMERGENCY" of the FACULTY OF MEDICINE OF THE COMPLUTENS UNIVERSITY OF MADRID under the direction of Professor Dr. F. Martin Santos. 1989-90 academic year.

- PROFESSOR of the Primary Care Surgery Course. Virgen de la Torre Hospital. Organizer: College of Physicians of Madrid and the Department of Health of the Community of Madrid. Madrid, June 1990.

- PROFESSOR of the Department of Surgical Pathology of Plastic and Reconstructive Surgery of the School of Nursing SALUS INFIRMORUM (Madrid School) of the Pontifical University of Salamanca from October 1992 to the present.

- TEACHER of the course "TRAUMATIC INJURIES OF THE CRANIAL ROD AND POSTERIOR SKIN". ASEPEYO, November 1993.

- PROFESSOR of the doctoral course "Behavioural Neurobiology" under the direction of Dr. R. García Cordovilla. Faculty of Science. Biology. Complutense University. Madrid. (1994-95, 1995-96, 1997-98 and 1998-99 academic years).

- Associate teacher of practical classes in surgical pathology at the Faculty of Medicine of the Complutense University of Madrid.

- Author of the topic "Soft tissue tumors" in the edition of the Curriculum of the specialty "Plastic and reconstructive surgery" of the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery. Edition of 1997.

Other experience

- DEPUTY CHIEF PHYSICIAN of the regional party Campo Real, Madrid, August 1981.

- Doctor of the company "EUROPE ASSISTANCE" from January 1984 to January 1989, holding the position of MEDICAL DIRECTOR, and also carrying out the transportation and repatriation of patients in critical condition.

- RESIDENT PHYSICIAN in intensive care medicine, who worked in the Intensive Care Unit of the Ramón y Cajal Hospital in Madrid from 1982 to 1986.

- ASSISTANT PHYSICIAN in the Intensive Care Unit of the Ramón y Cajal Hospital in Madrid in 1987.

- REGIONAL SPECIALIST FACULTY of the Intensive Care Service of the Alcalá de Henares Hospital from January 1988 to April 1989.

- RESIDENT PHYSICIAN in the specialty of plastic and reconstructive surgery, assigned to the service in the said specialty at the "Doce de Octubre" hospital from April 1989 to December 1993.

- Surgeon in the Department of Plastic and Aesthetic Surgery at HOSPITAL RUBER INTERNACIONAL under the direction of Dr. Antonio de la Fuente from January 1991 to November 1993.

- Surgeon in the Department of Plastic and Reconstructive Surgery at the HOSPITAL MONOGRAFICO ASEPEYO in Coslada (Madrid) from January 1992 to November 1993.

- REGIONAL FACULTY SPECIALIST in PLASTIC AND RECONSTRUCTIVE SURGERY at the 12 OCTOBER INSALUD HOSPITAL, Madrid, from January 1994 to May 2001.

- Private practice of reconstructive and aesthetic plastic surgery as Director of the Martin del Hierro Institute of Plastic Surgery, C/ General Ampudia, No. 6, 28003 Madrid.

- Private practice of reconstructive and aesthetic plastic surgery as team leader at LA LUZ CLINIC. Calle del Maestro Angel Lorca, 8. Madrid.

- Private practice of plastic, reconstructive and aesthetic surgery as Head of the Plastic Surgery Department of the MONTEPRINCIPE Hospital in Madrid.

PUBLICATIONS

45 papers for national and international conferences

40 publications in national and international journals

37 courses and symposia were held

Zhang Xuezhi

Professor

Leading physician

Doctor-scientist of ancient Chinese medicine Qihuang

A famous traditional Chinese medicine doctor in Beijing

Doctor of Medical Sciences

Director of the Institute of Integrative Traditional Chinese and Western Medicine, Peking University

Head of Department of Integrative Traditional Chinese and Western Medicine, Peking University First Hospital

Head of Department of Traditional Chinese Medicine, Peking University International Hospital

Deputy Head of the Department of Integrative Traditional Chinese and Western Medicine, Peking University

Academic Director of National Key Specialties of Traditional Chinese Medicine and Geriatrics

Consulting expert of the Central Commission for Health and Talents of Traditional Chinese Medicine in Beijing

Executive Director of the China Society of Traditional Chinese Medicine

Chairman of the Working Committee of Traditional Chinese Medicine• Director of the Chinese Society for Integrative Traditional Chinese and Western Medicine

Vice Chairman of the Professional Committee for Acupuncture Treatment

Vice President of the Branch of Integrative Traditional Chinese and Western Medicine of the Chinese Medical Association

Vice President of the Beijing Society of Traditional Chinese Medicine

Vice President of the China Medical Association of Integrative Traditional Chinese and Western Medicine

Chairman of the General Hospital Committee of the Chinese Medical Association

Vice President of the Beijing Society of Traditional Chinese Medicine

Chairman of the Professional Committee of Clinical Pharmacology

Permanent Member and Deputy Secretary General of the Traditional Chinese Medicine Working Committee of the General Hospital

Permanent member of the Department of General Medicine

Executive Director of the Beijing Association of Integrative Traditional Chinese and Western Medicine

Editorial board expert for reviewing the "Journal of Traditional Chinese Medicine", "Clinic of Modern Traditional Chinese Medicine", "Beijing Traditional Chinese Medicine" and others

Author of over 100 articles in SCI and other journals

Cardiology Department 

Education and Specialty: 

2003 - Medical Education, School of Medicine, Çukurova University 

2009 – Specialty, School of Medicine, Uludağ University 

2015- Associate Professor, Adana Training and Research Hospital 

Experience: 

2012 - 2015 – Head of Educational and Administrative Affairs, ENT Clinic, Haseki Training and Research Hospital (3 years) 

2009 – 2011, Conscription, Şevket Yılmaz Training and Research Hospital, Bursa 

2011-2013 Bursa State Hospital 

2013-2015 Seyhan Practice Hospital, Adana Training and Research Hospital 

2015-2016 Head of Department of Cardiology, Okmeydanı Training and Research Hospital 

February 2016 – July 2019, Head of Department of Cardiology, School of Medicine, Biruni University. 

Fields of Specialties: 

Complex Coronary Interventions 

Complex Peripheral Interventions 

Pacemaker Procedures 

Electrophysiological Study and Ablation 

Heart Valve Interventions (TAVI, Mitraclip, Mitral Balloon) 

Certificates: 

Board Certificate, European Society of Cardiology 

Board Certificate, Turkish Society of Cardiology 

Professional Memberships- Number Insignificant: 

1. European Society of Cardiology 

2. Turkish Society of Cardiology 

3. Member of Istanbul Medical Chamber 

Personal motto: Your heart is entrusted to us 

Researches and Articles: 

Articles published in international peer-review journals: 

1. *Uçar H*, Gür M, Koyunsever NY, Seker T, Türkoglu C, Kaypakli O, Sahin DY, Elbasan Z, Cayli M. Mean platelet volume is independently associated with renal dysfunction in stable coronary artery disease. Platelets (ISI). 2013 Jun; 25(4):274-278. doi: 10.3109/09537104.2013.805406. Epub 2013 Jun 17 

A2. *Uçar H*, Gür M, Yildirim A, Börekçi A, Gözükara MY, Seker T, Kaypakli O, Türkoglu C, Ozaltun B, Akyol S, Harbalioglu H, Sahin DY, Elbasan Z, Cayli M. Increased Aortic Stiffness Predicts Contrast-Induced Nephropathy in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Angiology (ISI). 2014 Oct;65(9):806-11. doi: 10.1177/0003319713504126. Epub 2013 Sep 26. 

A3. *Uçar H*, Gür M, Kivrak A, Koyunsever NY, Seker T, Akilli RE, Türkoglu C, Kaypakli O, Sahin DY, Elbasan Z, Tanboga HI, Cayli M. High-sensitivity cardiac troponin T levels in newly diagnosed hypertensive patients with different left ventricle geometry. Blood Pressure (ISI). 2014 Aug;23(4):240-7. doi: 10.3109/08037051.2013.840429. Epub 2013 Sep 23. 

A4. *Uçar H*, Mustafa Gür M, Gözükara MY, Kıvrak A, Kolcu Z, Akyol S, Kaypaklı O, Elbasan Z, Sahin DY, Türkoglu C, Seker T, Çaylı M. Relationship between mean platelet volume and morning blood pressure surge in newly diagnosed hypertensive patients. The Anatolian Journal of Cardiology (ISI). 2014 Apr 8. doi: 10.5152/akd.2014.5196. [Epub ahead of print]. 

A5. *Uçar H*, Gür M, Seker T, Kaypaklı O, Elbasan Z, Koyunsever NY, Türkoglu C, Özaltun B, Kuloglu O, Kalkan GY, Sahin DY, Çaylı M. High-Sensitivity Cardiac Troponin T is Associated with SYNTAX Score and Diabetes Mellitus in Patients with Stable Coronary Artery Disease. Journal of Clinical & Experimental Cardiology , 2013 Jun; 4(9):1-5. doi: 10.4172/2155-9880.1000263 

A6. *Uçar H*, Gür M, Gözükara MY, Kalkan GY, Baykan AO, Türkoğlu C, Kaypakl O, Seker T, Sen O, Selek S, Cayl M. Gamma glutamyl transferase activity is Independently associated with oxidative stress rather than SYNTAX score. Scand J Clin Lab Invest (ISI). 2014 Sep 2:1-6. [Epub ahead of print] 

A7. *Uçar H*, Gür M, Börrekçi A, Yıldırım A, Baykan AO, Kalkan GY,Koç M, Şeker T, Coşkun M, Şen Ö, Çaylı M. Relationship between extent and complexity of coronary artery disease and different left ventricular geometric patterns in patients with coronary artery disease and hypertension. The Anatolian Journal of Cardiology (ISI). DOI:10.5152/akd.2014.5747 

A8. Çaylı M, Elbasan Z, Gür M, Şeker T, *Uçar H*, Kuloğlu O, Şen O, Şahin DY, Yüksel Kalkan G. Modified flower petal technique in the treatment of isolated ostial left main and non-left main bifurcation lesions. Eurointervention. Accepted 2014 Oct. 20140324-02-R2 

A9. Baykan AO, Yüksel Kalkan G, Gür M, *Uçar H*, Acele A, Seker T, Sen O, Kaypakli O, Harbalioğlu H, Cayli M. Coronary Flow Velocity Reserve in Patients with Ascending Aorta Aneurysm. Echocardiography (ISI). 2014 Oct 7. doi: 10.1111/echo.12782. [Epub ahead of print] 

A10. Şeker T, Gür M, *Uçar H*, Türkoğlu C, Baykan AO, Özaltun B, Harbalıoğlu H, Kalkan GY, Kaypaklı O, Kuloğlu O, Şen Ö, Koç M, Çaylı M. Lower serum 25-hydroxyvitamin D level is associated with impaired myocardial performance and left ventricle hypertrophy in newly diagnosed hypertensive patients. The Anatolian Journal of Cardiology (ISI). DOI:10.5152/akd.2014.5637 

A11. Gözükara MY, Börekçi A, Gür M, Aksoy N, Seker T, Kaypaklı O, *Uçar H*, Türkoğlu C, Koç M, Makca I, Akyol S, Selek S, Caylı M. Gamma Glutamyl Transferase Activity is Associated With Both Paraoxonase Activity and Aortic Stiffness in Hypertensive Patients. J Clin Lab Anal (ISI). 2014 Aug 17. doi: 10.1002/jcla.21785. [Epub ahead of print] 

A12. Kalkan GY, Gür M, Baykan AO, *Uçar H*, Elbasan Z, Şahin DY, Koç M, Börekçi A, Çaylı M. Mean platelet volume is associated with aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease. The Anatolian Journal of Cardiology (ISI). DOI:10.5152/akd.2014.5576 

A13. Gür M, Türkoglu C, Taskın A, *Uçar H*, Börekçi A, Seker T, Gözükara MY, Kaypaklı O, Akyol S, Selek S, Sahin DY, Elbasan Z, Çayli M. Paraoxonase 1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow. Atherosclerosis (ISI). 2014 Jun;234(2):415-20. doi: 10.1016/j.atherosclerosis.2014.03.005. Epub 2014 Apr 3. 

A14. Sahin DY, Gür M, Elbasan Z, Kırım S, *Uçar H*, Seker T, Kaypaklı O, Uysal OK, Kıvrak A, Koyunsever NY, Akıllı RE, Caylı M. NT-proBNP predicts impaired myocardial function in newly diagnosed hypertensive patients with preserved ejection fraction. Clinical and Experimental Hypertension (ISI). 2014;36(5):289-94. doi: 10.3109/10641963.2013.810234. Epub 2013 Jul 18. 

A15. Caylı M, Gür M, Kalkan GY, Elbasan Z, Sahin DY, Koyunsever NY, Türkoglu C, Seker T, Kaypaklı O, Harbalıoglu H, Uçar. Gamma glutamyl transferase activity: Relationship with thoracic aortic intima media thickness and inflammation. Herz (ISI). 2014 Sep;39(6):761-766. Epub 2013 Aug 11. 

A16. Çaylı M, Gür M, Elbasan Z, Seker T, Türkoglu C, Kaypaklı O, Sahin DY, *Uçar H*, Kıvrak A, Koyunsever NY, Sen Ö. High-sensitivity cardiac troponin T predicts nondipper hypertension in newly diagnosed hypertensive patients. J Clin Hypertens (Greenwich) (ISI). 2013 Oct;15(10):731- 6. doi: 10.1111/jch.12176. Epub 2013 Aug 7. 

A17. Kalkan GY, Gür M, Baykan AO, Koyunsever NY, Kaypakli O, Sen O, Kuloglu O, Seker T, *Uçar H*, Akyol S, Elbasan Z, Sahin DY, Çayli M. Serum bilirubin level and aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease. Angiology (ISI). 2014 Apr;65(4):308-12. doi: 10.1177/0003319713507627. Epub 2013 Oct 24. 

A18. Gür M, *Uçar H*, Kuloglu O, Kıvrak A, Seker T, Türkoglu C, Ozaltun B, Kaypaklı O, Sahin DY, Elbasan Z, Tanboga HI, Caylı M. Estimated glomerular filtration rate is associated with both arterial stiffness and N-terminal pro-brain natriuretic peptide in newly diagnosed hypertensive patients. Clinical and Experimental Hypertension (ISI). 2014;36(6):374-9. doi: 10.3109/10641963.2013.827703. Epub 2014 Jan 16. 

A19. Gür M, Caylı M, *Uçar H*, Elbasan Z, Sahin DY, Gözükara MY, Selek S, Koyunsever NY, Seker T, Türkoglu C, Kaypaklı O, Aksoy N. Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis. Int J Cardiovasc Imaging (ISI). 2014 Jun;30(5):889-95. doi: 10.1007/s10554-014-0407-y. Epub 2014 Apr 4. 

A20. Budak YU, Huysal K, Polat M, Tarakçi G, *Uçar H*. Evaluation of the Steelex M600H coagulometer prothrombin time-international normalized ratio assay with Steelex test reagents. Biochem Med (Zagreb) (ISI). 2012 Jan; 22: 121-126 pp. 

A21. Seker T, Türkoglu C, *Uçar H*, Gür M, Sahin DY, Caylı M. Treatment of totally occluded aortic coarctation using a covered stent. Herz (ISI). 2014 Mar; DOI: 10.1007/s00059-013-3984-y [Epub ahead of print] 

A22. Börekçi A, Gür M, Türkoğlu C, Çaylı M, Selek S, Kaypaklı O, *Uçar H*, Coskun M, Seker T, Koç M, Gökdeniz T, Gözükara MY. Oxidative Stress and Paraoxonase 1 Activity Predict ContrastInduced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology (ISI). 2014 May; DOI: 10.1177/0003319714533588 [Epub ahead of print] 

A23. Kalkan GY, Gür M, Haydardedeoglu FE , Sinan Kırım S, Baykan AO, Kuloglu O, *Uçar H*, Sahin DY, Elbasan Z, Seker T, Turkoglu C, Yildirim A, Cayli M. The Association between Aortic Distensibility and Coronary Flow Reserve in Newly Diagnosed Diabetic Patients. Echocardiography (ISI). 2014 May; DOI: 10.1111/echo.12631 [Epub ahead of print] 

A24. Kalkan GY, Gür M, Koyunsever NY, Seker T, Gözükara MY, *Uçar H*, Kaypaklı O, Baykan AO, Akyol S, Türkoglu C, Elbasan Z, Sahin DY, Çaylı M. Serum 25-hydroxyvitamin D level and aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease. Journal of Clinical Laboratory Analysis (ISI). 2014 Aug 17. doi: 10.1002/jcla.21770. [Epub ahead of print]. 

A25. *Uçar H*, Karaagaç K, Serdar OA, Yetkin ZA, Aktürk Y, Karaagaç EU, Sarıcaoglu H, Arterial Elasticity Measurement in Patients with Behçet Disease. HealthMED (2012’ de ISI) 2012 May; 6: 3255-3261 pp. 

A26. Karaagaç K, *Uçar H*, Karaagaç E, Yetkin ZA, Aktürk Y. The Relation Betwen Aspirin Resistance and Mean Platelet Volume in Patients with Significant Coronary Artery Stenosis. HealthMED (2012’ de ISI) 2012 May ;6: 3701-3705 pp. 

A27. Cander S, Coban S Altuner S, Gül ÖÖ, Yetgin ZA, Akkurt A, *Uçar H*, Tuncel E. Prevalence and Correlates of Erectile Dysfunction in Type 2 Diabetes Mellitus: A Cross-Sectional SingleCenter Study Among Turkish Patients. Metabolic Syndrome and Related Disorders (ISI). 2014 Aug;12(6):324-9. doi: 10.1089/met.2013.0150. Epub 2014 Mar 25. 

A28. Abalı G, *Uçar H*, Elbasan Z , Gür M ,Seker T, Koyunsever NY, Çaylı M, Akpınar O. Effect of Statin on Neutrophil to Lymphocyte Ratio in Patients with Coronary Artery Disease. Experimental & Clinical Cardiology (ISI). 2014 May 

A29. Effect of fasting on 24-h blood pressure values of individuals with no previous history of hypertension. Seker A, Demirci H, Ocakoglu G, Aydin U, Ucar H, Yildiz G, Yaman O. Blood Press Monit. 2017 Oct;22(5):247-252. doi: 10.1097/MBP.0000000000000244 

A30. The importance of the neutrophil-to-lymphocyte ratio in patients with hypertrophic cardiomyopathy. Ozyilmaz S, Akgul O, Uyarel H, Pusuroglu H, Gul M, Satilmisoglu MH, Bolat I, Ozyilmaz I, *Uçar H*, Yildirim A, Bakir I. Rev Port Cardiol. 2017 Apr;36(4):239-246. doi: 10.1016/j.repc.2016.09.014. Epub 2017 Mar 18. English, Portuguese 

A31. A case of stent thrombosis presenting as acute myocardial infarction related to right coronary artery originating from the left coronary system. Ermis E, Kahraman S, Ucar H, Allahverdiyev S. Intractable Rare Dis Res. 2018 Feb;7(1):58-60. doi: 10.5582/irdr.2018.01001. 

A32. Triple Coronary Artery Thrombosis Presenting as Acute Anterior ST-Segment Elevation Myocardial Infarction. Ermis E, Kahraman S, Ucar H, Ozyılmaz SO, Allahverdiyev S. Int J Angiol. 2018 Dec;27(4):223-226. doi: 10.1055/s-0037-1608959. Epub 2017 Dec 12 

A33. Relationship between blood pressure variability and cognitive function in geriatric hypertensive patients with well-controlled blood pressure. Yıldırım E, Ermis E, Allahverdiyev S, Ucar H, Yavuzer S, Yavuzer H, Cengiz M. Aging Clin Exp Res. 2019 Feb 1. doi: 10.1007/s40520- 019-01141-6. 

C2. Book chapters written in other languages: 

C2.1. Hung JS, Lau KW, *Uçar H*, Çaylı M, Çaylı M, Practical Handbook: Practical Handbook of Advanced Interventional Cardiology (Inoue balloon mitral valvuloplasty),437-473 pp, Adana / Turkey, Çukurova Nobel Medical Bookstore, 2014 

C2.2. Feldman T, Nguyen TN, *Uçar H*, Çaylı M, Çaylı M, Practical Handbook: Practical Handbook of Advanced Interventional Cardiology (retrograde percutaneous aortic valvuloplasty), 475-486 pp, Çukurova, Adana / Turkey, Çukurova Nobel Medical Bookstore, 2014 

D. Articles published in local peer-review journals: 

D1. *Uçar H*, Gür M, Seker T, Sahin DY, Kalkan GY, Türkoglu C, Yıldırım A, Kaypaklı O, Elbasan Z, Çaylı M. Impaired kidney function is associated with syntax scorein patients with stable coronary artery disease. Archive of Turkish Society of Cardiology, 2014; DOI: 10.5543/tkda.2014.67790 

D2. Kalkan GY, Gür M, Elbasan Z, Baykan AO, Kuloğlu O, Sahin DY, Seker T, Haydardedeoglu FE, Şen Ö, *Uçar H*, Kırım S, Çayli M. Left Ventricle Geometry Affects Coronary Flow Reserve in Diabetic Patients. Archive of Turkish Society of Cardiology, Doi: 10.5543/tkda.2015.59432 

D3. *Uçar H*, Karaagaç K, Tiryakioglu S. Woven Left Coronary Artery: A Case Report. Turkish Clinics Journal of Medical Research-Case Reports 2014 (22), 5-6 pp. 

D4. Albayrak S, Kemal Karaagaç K, Baran I, Yetgin ZA, *Uçar H*, Aydınlar A, "Carvedilol and Metoprolol in Acute Myocardial Infarction Early Effect of Oxidized LDL and Paraoxonase-1 Activity Abant Medical Journal 2013; DOI: 10.5505/abantmedj.2013.30592 

D5. Gür AK, Eker E, Akyol A, Akdag S, Kolcu Z, Odabası D, *Uçar H*. Useage of Intra-aortic Baloon Pump in the Open Heart Surgeries. Medical Journal of School of Medicine, Harran University 2014 (11), 10-14 pp. 

D6. Aktürk Y, Dilek Yesilbursa D, *Uçar H*, Yücel E, Özdabakoglu O, Eryılmaz S, Sensoy B, Serdar OA, Aydınlar A. The Effect of Diurnal Blood Pressure Change on Heart Rate Recovery After Cardiac Stress Testing in Hypertensive Patients Receiving Treatment. Uludağ University, School of Medicine Journal 2008 (34), 9-13 pp. 

D7. Yesilbursa D, Aydinlar A, Karaagaç K, *Uçar H*, Aktürk Y, Yetgin ZA. Comparison of Depression and Anxiety Levels in Patients With Acute Coronary Syndrome. Journal of Clinical and Analytical Medicine 2014; DOI: 10.4328/JCAM.1443 

D8. Emül A, Karaagaç K, Yetgin ZA, *Uçar H*, Baran I, Aydınlar A. The Effects of Metabolic Syndrome on Aortic Distensibility in Patients with Angiographically Normal Coronary Arteries. Sakarya Medical Journal 2013; DOI: 10.5505/sakaryamj.2013.69672 

D9. Assessment of side branch patency using a jailed semi-inflated balloon technique with coronary bifurcation lesions. Ermiş E, *Uçar H*, Demirelli S, İpek E, Gür M, Çaylı M. Archive of Turkish Society of Cardiology 2018 Jul;46(5):340-348. doi: 10.5543/tkda.2018.47347.

Dr. Ruiz Castilla is a prestigious specialist in plastic, aesthetic and reconstructive surgery, ranked among the top 5 plastic surgeons in Spain by Forbes magazine in 2018, 2019 and 2020. She has more than 15 years of experience in the profession and extensive training in various specialties. In this sense, he has extensive experience in the medical and surgical treatment of breast pathology, skin oncology, burns, facial fractures, hand surgery and skin changes, using both traditional and microsurgical techniques.

She is currently Head of the Plastic, Reconstructive and Aesthetic Surgery Service at the Quironsalud Hospital of Barcelona and Head of the Plastic Surgery Service at the Dexeus University Hospital since November 2021.

Throughout his career, he has combined public health work with teaching, and has also carried out important outreach and research work. She has authored and co-authored numerous scientific articles and publications, and is a regular speaker at specialized conferences. She is also involved as an investigator in several lines of research in the field of monitoring and using new treatments for burn patients.

Dr. Ruiz has practiced in prestigious national and international centers and currently directs her own Institute of Plastic, Reconstructive and Aesthetic Surgery, Institut Ruiz Castilla.

Professional experience

1998–2004: Degree in Medicine and Surgery at the Autonomous University of Barcelona

2005–2010: Specialized residency in plastic, reconstructive and aesthetic surgery

2009-2010: Master's degree entitled "Expert in Microsurgical Techniques. XII Theoretical and Practical Course in Microsurgical Techniques". Hand and Peripheral Nerve Surgery Department, Sabadell Hospital. (Director: Dr. J. Ramon Solé)

2018 PhD in Surgery - Autonomous University of Barcelona: "The role of the IL33/ST2 axis in burn patients", unanimously awarded Summa Cum Laude.

2018 Robotic Surgery Course at the Faculty of Medicine, University of Lorraine, France.

Professional career

2016 – present: Head of Service, Department of Plastic, Reconstructive and Aesthetic Surgery, Quirónsalud Barcelona Hospital

2010 – 2018 Specialist in the Plastic, Reconstructive and Burns Surgery Service at the Vall d'Hebron University Hospital.

2013 – 2017 Specialist in Plastic, Reconstructive and Aesthetic Surgery at the Obstetrics and Gynecology Center, Mataró.

Extensive experience in medical and surgical treatment of breast pathology, skin oncology, burns, facial fractures, hand surgery and altered skin using both traditional and microsurgical methods.

Participation in the world's first total face transplant.

Participation in the second face transplant at the Vall d'Hebron Hospital.

Membership in scientific societies

Member of the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery

Member of the Catalan Society of Plastic, Reconstructive and Aesthetic Surgery

Member of the American Society of Plastic Surgeons

Founding member of the Women's Organization of Plastic, Reconstructive and Aesthetic Surgery of Spain (WOPRASS).

Research and Teaching

Teaching Assistant for the Plastic Surgery Course at the Faculty of Medicine at the Autonomous University of Barcelona (Teaching Unit: Vall d'Hebron)

Lecturer in the course on comprehensive care of burn patients, part of the postgraduate course entitled "Nursing care for people with burns", University Hospital Vall d'Hebron

Lecturer in the course on comprehensive treatment of burn patients (Josep Trueta University Hospital) 2010

Organiser of the International Conference on Plastic and Cosmetic Surgery, London, 11-12 March.

Dr Rivera obtained his Degree in Medicine and Surgery at the University of Seville and continued his academic training until he completed a University Master in Tissue Engineering at the Histology Department of the University of Granada and later obtained the speciality in Plastic, Repair and Cosmetic Surgery at the Virgen de las Nieves (Granada) University Hospital.

Dr Rivera has developed extensive experience in the area of surgery, where he has been in practice for over ten years. Always at the forefront of new technologies applied to surgical techniques, he is a habitual participant in specialist scientific forums as well as national and international conventions.

Professional Experience

• 2007-2012 - Plastic, Repair and Cosmetic Surgery Resident Doctor at the Virgen de las Nieves (Granada) University Hospital

• May 2012 - Currently, Co-director of the Plastic, Cosmetic and Repair Surgery Unit of the Quirónsalud Marbella Hospital.

• May 2013 - Currently, Co-director of the Plastic, Cosmetic and Repair Surgery Unit of the Quirónsalud Campo de Gibraltar Hospital.

• He has also been part of General Surgery and Traumatology, Maxillofacial Surgery and Major Burn Ward teams. Additionally, he has cooperated with the Plastic Surgery Unit of the Teknon Clinic in Barcelona.

The Plastic, Cosmetic and Repair Surgery Unit of the Quirónsalud Marbella Hospital performs the most advanced treatments in Cosmetic Surgery and Medicine with the total guarantee that the patient is treated within a hospital environment, thus ensuring the highest level of safety during the surgical procedure and the recovery time.

Our team of specialists combine their solid professional expertise in the correction of congenital or acquired anomalies affecting the shape or the appearance of your body. As this speciality deals with various areas and systems, the experts often work in conjunction with other medical areas.

With regards to female cosmetic surgery, the Plastic, Cosmetic and Repair Surgery Unit of the Quirónsalud Marbella Hospital specialises in the augmentation and reduction of breasts, breast lift, tuberous breast correction, abdominoplasty, arms and thigh lift, surgery of the genitalia and reconstructive surgery after a mastectomy at the Breast Cancer Unit. We also perform male breast reduction and facial surgical procedures such as facial lift, eyelid surgery, nose remodelling, ear correction surgery and double-chin surgery.

He is an expert in cardiac arrhythmia, pacemaker implantation, internal defibrillators and catheter ablation; and he conducts diagnostic electrophysiological studies.

He also carries out extensive teaching work as a Senior Lecturer of the Medicine Department of the Malaga University, where he teaches the subject Diseases of the Circulatory and Respiratory Systems to fourth-year medical students.

He is the author of over 100 scientific publications in influential journals. At the same time, he has contributed to the preparation of clinical practice guides and is the author of 23 books and chapters of scientific titles in the speciality.

Professional experience

University Degree in Medicine and Surgery (1978) obtained at the Zaragoza University.

Degree as Doctor in Medicine by the Zaragoza University with final thesis “Cardiac Automatism and Conduction in a Model of Experimental Heterotopic Cardiac Transplantation. Effects of Verapamil”, which obtained a cum laude award.

Training as a Resident Doctor in Cardiology at Clínica Puerta de Hierro in Madrid (1979-1984).

Cardiology Medical Consultant and the Head of the Arrhythmia Unit at Clínica Puerta de Hierro (1985-1992).

Other positions:

Coordinator of the Implantable Defibrillator working team of the Spanish Cardiology Society (2009 – 2016).

Member of the European Society of Cardiology.

Member of the European Heart Rhythm Association.

Member of the Spanish Cardiology Society.

Member of the Andalusian Cardiology Society.

Member of the Editorial Committee of the Spanish Cardiology Journal.

Member of the Editorial Committee of Cardiocore.

Member of the Editorial Committee of Cardiac Stimulation Notebooks.

The Cardiology Unit of Quirónsalud Marbella Hospital is made up of a medical team with large experience in the diagnosis and treatment of heart diseases, as well as employing the most advanced technologies, both in the clinical area and in the area of haemodynamics and arrhythmia.

Diseases, treatments and techniques:

• Clinical cardiology

- Adult and children cardiology consultation with the performance of supplementary tests, all within one appointment.

- Specific consultations for arrhythmia

- Paedriatic cardiology

- Colour Doppler echocardiography and stress echocardiography

- Stress test

- 24-hour and long-term Holter EKG

- CT coronary angiogram

- Cardiac magnetic resonance imaging (MRI)

- Tilt table testing

- Cardiac rehabilitation

Cardiac haemodynamics

- Diagnostic cardiac catheterisation and percutaneous treatment of ischaemic heart disease with angioplasty and stent implant

- Myocardial infarction percutaneous treatment programme

- Transcatheter aortic valve implantation (TAVI)

- Percutaneous repair of the mitral valve (Mitral clip)

- Percutaneous closure of interatrial communication

- Percutaneous closure of left atrial appendage

Arrhythmia Unit 

- Diagnostic electrophysiological study 

- Catheter ablation

 - Cryoablation of atrial fibrillation

 - Ablation using a complex arrhythmic substrate navigator

 - Pacemaker implantation 

- Automatic endovenous and subcutaneous implantable

defibrillator

Cardiac surgery 

- Surgery with and without extracorporeal circulation

- Minimally-invasive surgery with an early extubation

• - Repair of mitral and aortic valves